| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/16/2002 | EP0952839B1 Green ointment |
| 01/16/2002 | EP0886515B1 Use of n-aryl-2-hydroxyalkylamides for stimulating or inducing hair growth and/or arresting hair loss |
| 01/16/2002 | CN1331801A Kidney disease detection and treatment |
| 01/16/2002 | CN1331694A Antihistaminic spiro compounds |
| 01/16/2002 | CN1331688A Aminopyrazole derivatives |
| 01/16/2002 | CN1331680A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/16/2002 | CN1331679A 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands |
| 01/16/2002 | CN1331674A Sulfonamide hydroxamates |
| 01/16/2002 | CN1331597A Use of bisphosphonates for prevention and treatment of infectious processes |
| 01/16/2002 | CN1331590A Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating disease associated with increase of AT-1 or AT-2 receptors |
| 01/16/2002 | CN1331587A Spray-type consmetic compsn. and matrix used in said compsn. for dermal administration |
| 01/16/2002 | CN1330951A Chinese medicine for treating dermatopathy (leukoderma and psoriasis) |
| 01/16/2002 | CN1330939A Foot-therapeutic liquid |
| 01/16/2002 | CN1330938A Medicine for treating thrombocytopenia and its application in treating radiation disease |
| 01/16/2002 | CN1330936A Medicine prescription of treating burn |
| 01/16/2002 | CN1330932A Chinese medicine for treating psoriasis |
| 01/16/2002 | CN1330929A Chinese-medicinal pill for treating dermatopathy |
| 01/16/2002 | CN1330923A Medicine for treating foot ringwoorm |
| 01/16/2002 | CN1077794C Fenciling capsule for curing comedo |
| 01/16/2002 | CN1077789C Hanfang bathing agent and its making method |
| 01/15/2002 | US6339154 (2-Substituted oxyphenyl) alkanamide derivative, hair growth promoter and external composition for skin using the same |
| 01/15/2002 | US6339094 2-acylaminopropanamines as tachykinin receptor antagonists |
| 01/15/2002 | US6339071 For preventing proliferation of tumor cells |
| 01/15/2002 | CA2199995C Use of 2,4-diamino pyrimidine 3-oxide or a salt thereof for treating collagen maturation and structuring disorders |
| 01/15/2002 | CA2050946C Use of polysaccharides in preparations for wound treatment |
| 01/13/2002 | CA2353057A1 Topical treatment of skin |
| 01/12/2002 | CA2352610A1 Formulations containing non-substitute flavylium-salt-type compounds in position 3 for skin colouring and one organomodified silicone |
| 01/12/2002 | CA2352605A1 Formulations containing non-substitute flavylium-salt-type compounds in position 3 for skin colouring and uses |
| 01/12/2002 | CA2352595A1 Formulations containing at least one monocarbonyl or polycarbonyl self-tanning substance and one non-substitute flavylium-salt-type compound in position 3 for skin colouring and uses |
| 01/12/2002 | CA2352450A1 Formulation consisting of at least one uv filter and one non-substitute flavylium salt in position 3 for skin colouring and uses |
| 01/11/2002 | CA2352618A1 Vitamin- and mineral-salt-based formulation for reducing loss and/or promoting regrowth of hair |
| 01/10/2002 | WO2002002773A2 Dual specificity antibodies and methods of making and using |
| 01/10/2002 | WO2002002771A2 Human sparc-homologous (hsparc-h1) gene and methods and uses thereof |
| 01/10/2002 | WO2002002645A1 COLD WATER SOLUBLE β-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME |
| 01/10/2002 | WO2002002640A2 Antibodies to human mcp-1 |
| 01/10/2002 | WO2002002638A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002629A2 Grf2-binding proteins and applications thereof |
| 01/10/2002 | WO2002002625A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
| 01/10/2002 | WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 01/10/2002 | WO2002002589A1 Novel antiandrogenic agent |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002566A1 Therapeutic compounds and methods |
| 01/10/2002 | WO2002002564A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/10/2002 | WO2002002562A2 Heteropolycyclic inhibitors |
| 01/10/2002 | WO2002002556A2 AZA-BRIDGED-BICYCLIC AMINO ACID DERIVATIVES AS α4 INTEGRIN ANTAGONISTS |
| 01/10/2002 | WO2002002552A1 Quinazoline ditosylate salt compounds |
| 01/10/2002 | WO2002002551A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 01/10/2002 | WO2002002549A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/10/2002 | WO2002002541A2 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | WO2002002525A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 01/10/2002 | WO2002002498A1 Method for producing a non-fatty softener based on wax-esters |
| 01/10/2002 | WO2002002140A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide |
| 01/10/2002 | WO2002002133A2 Peptide composition for treatment of periodontal diseases and prevention of skin aging |
| 01/10/2002 | WO2002002129A1 Use of grifola frondosa fungus extracts |
| 01/10/2002 | WO2002002118A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
| 01/10/2002 | WO2002002105A1 Therapeutic combinations of fatty acids |
| 01/10/2002 | WO2002002095A2 Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin |
| 01/10/2002 | WO2002002090A2 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | WO2002002079A1 Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives |
| 01/10/2002 | WO2002002072A2 Skin care cosmetic compositions containing phosphates and/or sulfates of branched alcohols and/or ethoxylates thereof |
| 01/10/2002 | WO2002002068A2 Cosmetic skin care compositions and containing gum mastic |
| 01/10/2002 | WO2002002059A1 Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions |
| 01/10/2002 | WO2002002056A2 Method of treatment of seborrheic dermatitis |
| 01/10/2002 | WO2002002051A2 Use of a polysaccharide excreted by the vibrio diabolicus species in bone repair |
| 01/10/2002 | WO2001074164A9 Methods of modulating hair growth |
| 01/10/2002 | WO2001059071A3 Methods of preparing and using a viral vector library |
| 01/10/2002 | WO2001056993A3 Pyrazole compositions useful as inhibitors of erk |
| 01/10/2002 | WO2001051066A3 Reduction in bacterial colonization by administering bacteriophage compositions |
| 01/10/2002 | WO2001051042A3 Treatment of diabetic ulcers |
| 01/10/2002 | WO2001051027A3 Polymer blends as biodegradable matrices for preparing biocomposites |
| 01/10/2002 | WO2001049250A3 Treatment of acne using lipoic acid |
| 01/10/2002 | WO2001045730A3 Tweak receptor |
| 01/10/2002 | WO2001044455A3 Antisense oligonucleotides for the inhibition of expression of type i procollagen |
| 01/10/2002 | WO2001036425A3 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 01/10/2002 | WO2001021191A3 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 01/10/2002 | WO2001012664A3 Notch receptor ligands and uses thereof |
| 01/10/2002 | WO2000055332A3 Human regulators of intracellular phosphorylation |
| 01/10/2002 | US20020004532 Low emulsifier multiple emulsions |
| 01/10/2002 | US20020004514 Anticancer compound and enantiomer separation method useful for synthesizing said compound |
| 01/10/2002 | US20020004492 Polypeptides; wound healing agent, antiinflammatory agent |
| 01/10/2002 | US20020004489 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | US20020004063 Methods and apparatus for drug delivery involving phase changing formulations |
| 01/10/2002 | US20020004056 Spirooxathiolane quinuclidine derivatives useful as drugs which promote the secretion of sebaceous and sweat glands through oral or parenteral administration |
| 01/10/2002 | US20020004034 Use of sunscreen combinations comprising, as essential constituent, 4,4'-diarylbutadienes as photostable UV filters in cosmetic and pharmaceutical preparations |
| 01/10/2002 | DE10032165A1 Verwendung von physiologisch verträglichen Sulfinsäuren als Antioxidans oder Radikalfänger in kosmetischen oder dermatologischen Zubereitungen The use of physiologically compatible sulfinic acids as an antioxidant or free-radical scavengers in cosmetic or dermatological preparations |
| 01/10/2002 | DE10031971A1 Polymorphe Formen/Hydrate von N-[4-(3-Chlor-4-fluor-phenylamino)-7-(3-morpholin-4-yl-propoxy)-chinazolin-6-yl]-acrylamid Dihydrochlorid, Verfahren zu ihrer Herstellung sowie die Verwendung derselben zur Herstellung von Medikamenten mit irreversibler Tyrosinkinasehemmwirkung Polymorphic forms / hydrates of N- [4- (3-chloro-4-fluoro-phenylamino) -7- (3-morpholin-4-yl-propoxy) -quinazolin-6-yl] -acrylamide dihydrochloride, processes for their preparation and to the use thereof for the preparation of medicaments with irreversible Tyrosinkinasehemmwirkung |
| 01/10/2002 | DE10019714A1 Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
| 01/10/2002 | CA2630062A1 Methods for treating graft versus host disease and immune disorders associated with rejection using a soluble ctla4 molecule |
| 01/10/2002 | CA2415123A1 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | CA2415088A1 Aza-bridged-bicyclic amino acid derivatives as .alpha.4 integrin antagonists |
| 01/10/2002 | CA2414885A1 Heteropolycyclic inhibitors |
| 01/10/2002 | CA2414807A1 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | CA2414799A1 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | CA2414468A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 01/10/2002 | CA2414352A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
| 01/10/2002 | CA2414347A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide |
| 01/10/2002 | CA2413715A1 Grf2-binding proteins and applications thereof |